SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

65 hedge funds and large institutions have $218M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-3
Holders Change %
-4.41%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
7
Increased
24
Reduced
23
Closed
10
Calls
$247K
Puts
Net Calls
+$247K
Net Calls Change
+$162K
Name Holding Trade Value Shares
Change
Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$46.1M
FP
2
Flagship Pioneering
Massachusetts
$29.3M
AIM
3
ARK Investment Management
Florida
$27.4M +$4.86M +53,208 +22%
BlackRock
4
BlackRock
New York
$18.4M +$222K +2,429 +1%
RG
5
Redmile Group
California
$15M -$39.7K -434 -0.3%
DM
6
Deerfield Management
New York
$11.6M
SB
7
Samsara BioCapital
California
$9.69M
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.24M +$2.03M +22,180 +33%
NAMA
9
Nikko Asset Management Americas
New York
$6.26M +$6.24M +68,246 +33,785%
Sumitomo Mitsui Trust Group
10
Sumitomo Mitsui Trust Group
Japan
$6.26M +$6.26M +68,448 New
BBA
11
Baker Bros. Advisors
New York
$5.25M
State Street
12
State Street
Massachusetts
$3.85M +$98.4K +1,077 +3%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$3.67M -$6.31K -69 -0.2%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$3.32M +$1.09M +11,936 +49%
Northern Trust
15
Northern Trust
Illinois
$2.8M +$2.56K +28 +0.1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.66M +$373K +4,086 +16%
Renaissance Technologies
17
Renaissance Technologies
New York
$2.02M +$875K +9,580 +77%
CS
18
Candriam SCA
Luxembourg
$1.87M
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$1.44M -$1.39M -15,263 -49%
Connor, Clark & Lunn Investment Management (CC&L)
20
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.09M -$33.8K -370 -3%
Charles Schwab
21
Charles Schwab
California
$1.03M -$129K -1,414 -11%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$1.03M +$218K +2,381 +27%
WCM
23
Wedge Capital Management
North Carolina
$762K +$201K +2,194 +36%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$761K -$11.8K -129 -2%
AA
25
ALPS Advisors
Colorado
$743K +$32.2K +352 +5%